Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta‐Analysis
Authors:
Open Access
- 23 September 2024
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 38 (12) , 5672-5689
Abstract
Knee osteoarthritis (OA) has recently been ranked as the 11th highest contributor to global disability. More than 40% of patients use complementary and alternative medicine including supplements containing phytoextracts with anti‐inflammatory properties as those from the Boswellia genus. The aim of this meta‐analysis was to evaluate the efficacy of phytoextracts from the oleogum resin of the Boswellia genus as supplementation for patients affected by knee OA. Four electronic databases were used for the research and PRISMA statements were followed throughout the study. The following inclusion criteria were used: (a) the subjects of the study were humans with a diagnosis of knee OA reported by medical staff; (b) randomization and the presence of control (placebo, negative or positive control), and (c) outcomes reported with WOMAC and/or visual analog scale (VAS) score. Publication bias was assessed with a funnel plot and through the Egger test. The Jadad scale was used in order to assess the quality of the studies included. The statistical heterogeneity was assessed using I2 statistics. Results of meta‐analysis and subgroup analysis were reported using a forest plot. A total of 13 studies involving 850 (WOMAC) and 1185 (VAS) patients met the inclusion criteria. The meta‐analysis did not detect a significant effect of the use of Boswellia extracts between the control and the treatment groups due to the high heterogeneity of the studies (p = 0.0865 for WOMAC) and (p = 0.3966 VAS). However, the subsequent subgroup analysis demonstrated the significant beneficial effect of Boswellia extracts in the treatment of knee OA with respect to a placebo (lower WOMAC score in the treatment groups). This was also confirmed in the meta‐regression applied to the WOMAC scores. This is an important finding as people exposed to NSAID‐related adverse effects could benefit from the use of Boswellia extracts. However, further high‐quality studies are needed to establish the clinical efficacy of extracts from the genus Boswellia.Keywords
This publication has 48 references indexed in Scilit:
- Interventions for osteoarthritis pain: A systematic review with network meta-analysis of existing Cochrane reviewsOsteoarthritis and Cartilage Open, 2022
- Cochrane Handbook for Systematic Reviews of Interventions2019
- A pilot, randomized, double‐blind, placebo‐controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the kneePhytotherapy Research, 2019
- Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trialClinical Rheumatology, 2017
- Rating of Athletic and Daily Functional Activities2017
- Boswellic Acids and Their Role in Chronic Inflammatory Diseases2016
- A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal RemediesPhytotherapy Research, 2016
- Australians with osteoarthritis; the use of and beliefs about complementary and alternative medicinesComplementary Therapies in Clinical Practice, 2014
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Arthritis Care & Research, 2011
- The “MESACA” study: Methylsulfonylmethane and boswellic acids in the treatment of gonarthrosisAdvances in Therapy, 2011